Medicare Enrolled

Dr. Rebecca Runyan Dowdy, NP

Women's Health Nurse Practitioner · Houston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
15003 FM 529 RD, Houston, TX 77095
7132308677
In practice since 2006 (19 years)
NPI: 1336218981 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Runyan Dowdy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Runyan Dowdy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Runyan Dowdy

Dr. Rebecca Runyan Dowdy is a women's health nurse practitioner in Houston, TX, with 19 years in practice. Based on federal Medicare data, Dr. Runyan Dowdy performed 147 Medicare services across 136 unique beneficiaries.

Between the years covered by Open Payments, Dr. Runyan Dowdy received a total of $1,612 from 29 pharmaceutical and/or device companies across 57 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in women's health nurse practitioner. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Runyan Dowdy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 28% volume in TX$ $1,612 industry payments

Medicare Practice Summary

Medicare Utilization ↗
147
Medicare services
Top 28% in TX for women's health nurse practitioner
136
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~8 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Cervical or vaginal cancer screening; pelvic and clinical breast examination70$32$80
Office visit, established patient (30-39 min)61$65$256
Automated urinalysis16$2$4
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,612
Total received (2021-2024)
Avg $403/year across 4 years
Top 11% in TX for women's health nurse practitioner
29
Companies
57
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,612 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$413
2023
$656
2022
$275
2021
$268

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Myriad Women's Health, Inc.
$315
Astellas Pharma US Inc
$145
GlaxoSmithKline, LLC.
$120
AbbVie Inc.
$110
ABBVIE INC.
$100
Otsuka America Pharmaceutical, Inc.
$91
Bayer HealthCare Pharmaceuticals Inc.
$88
Sumitomo Pharma America, Inc.
$85
Myovant Sciences Inc.
$51
MAYNE PHARMA INC.
$42
Organon LLC
$39
Exeltis, USA Inc.
$37
Evofem Biosciences, Inc.
$36
SHIELD THERAPEUTICS INC
$35
TherapeuticsMD, Inc.
$34
Medtronic, Inc.
$33
Shield Therapeutics Inc
$31
Bayer Healthcare Pharmaceuticals Inc.
$25
Biogen, Inc.
$22
Hologic Sales and Service, LLC
$22
Aspira Women's Health Inc
$21
Exact Sciences Corporation
$18
Pacira Pharmaceuticals Incorporated
$17
Merck Sharp & Dohme Corporation
$17
Davol Inc.
$17
Agile Therapeutics, Inc.
$16
ASCEND THERAPEUTICS US, LLC
$16
Lilly USA, LLC
$14
Avion Pharmaceuticals
$13
Top 3 companies account for 36.0% of total payments
Associated products mentioned in payments ›
ACCRUFER · AFFIRM PRONE BIOPSY SYSTEM · ANNOVERA · BEXSERO · Balcoltra · Cologuard Collection Kit · ESTROGEL · Exparel · GEMTESA · INTERSTIM · Kyleena · LO LOESTRIN FE · MYFEMBREE · MYRISK · NEXPLANON · ORIAHNN · ORILISSA · OVA1 · Phexxi · REXULTI · SLYND · Twirla · Veozah · ZEPBOUND · ZURZUVAE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1,097 per 100 Medicare services performed
Looking for a women's health nurse practitioner in Houston?
Compare women's health nurse practitioners in the Houston area by procedure volume, costs, and industry payment transparency.
Browse women's health nurse practitioners nearby

Geographic Context

Women's Health Nurse Practitioners within 10 mi
115
Per 100K population
2.4
County median income
$73,104
Nearest hospital
LONE STAR BEHAVIORAL HEALTH CYPRESS
5.9 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Runyan Dowdy is a clinical cardiology specialist, with above-average Medicare volume (top 28% in TX), and high industry engagement (low-engagement, top 11%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Runyan Dowdy experienced with cervical or vaginal cancer screening; pelvic and clinical breast examination?
Based on Medicare claims data, Dr. Runyan Dowdy performed 70 cervical or vaginal cancer screening; pelvic and clinical breast examination services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Runyan Dowdy receive payments from pharmaceutical companies?
Yes. Dr. Runyan Dowdy received a total of $1,612 from 29 companies across 57 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Runyan Dowdy's costs compare to other women's health nurse practitioners in Houston?
Dr. Runyan Dowdy's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Runyan Dowdy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →